Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 04, 2021

SELL
$7.67 - $13.77 $121,883 - $218,819
-15,891 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$12.07 - $17.95 $62,365 - $92,747
-5,167 Reduced 24.54%
15,891 $192,000
Q3 2020

Nov 05, 2020

BUY
$14.16 - $19.45 $132,155 - $181,526
9,333 Added 79.6%
21,058 $342,000
Q1 2020

May 11, 2020

BUY
$5.79 - $11.83 $67,887 - $138,706
11,725 New
11,725 $85,000
Q3 2018

Nov 06, 2018

SELL
$3.0 - $4.05 $96,300 - $130,005
-32,100 Closed
0 $0
Q2 2018

Jul 31, 2018

BUY
$3.15 - $4.7 $101,115 - $150,870
32,100 New
32,100 $106,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.